Deep Lens

Stale historical data is often only the best guess on broad I/E criteria. However, because our Real-Time Feasibility Dashboard integrates EMR and geometric data, we can give you up to date insights on your target patients. Learn more here: https://bit.ly/3yBuWgj

The goal of precision medicine is simply to deliver the right cancer treatment to the right patient at the right time. Oncology is the one therapeutic area that strongly supports this goal.

As more cellular treatments become FDA-approved, the need for established cellular therapy programs in the community setting will be crucial to expanding the availability of these novel treatments to patients. Learn more...

https://bit.ly/3yYU424

Are Cell and Gene Therapy Programs Primed for Community Oncology? Deep Lens' Director of Provider Network Amy Zuchelkowski shares her perspective on bringing cell and gene therapies to community oncology practices.

Are Cell and Gene Therapy Programs Primed for Community Oncology?

Offering cell-based therapy is uncharted territory for many community oncology practices. The treatments are seen as groundbreaking, and many patients desire access. Clinical trials allow for this access to the latest and greatest therapies in addition to close monitoring of care by the entire research team.


https://bit.ly/3N08Idi

"With the addition of automated molecular-based patient matching, we see VIPER giving us much greater granularity into how we work with our provider sites to drive greater patient engagement." - James Langford, AVITA Biomedical.

https://bit.ly/3xk8vf2

Does your clinical research department perform site audits or take other measures to ensure the quality of data submitted with a new drug application (NDA)?

https://bit.ly/3xp7J0l

On the Importance of Self-Audits in Clinical Research Deep Lens' Director of Provider Network Amy Zuchelkowski shares her perspective on preparing for FDA audits through diligence in reporting and record keeping.

Most clinical trial research sites under enroll patients. Our Real Time Feasibility Dashboard enables you to discover the best sites to activate for your trials: https://bit.ly/3xO4T6i

Stale historical data is often only the best guess on broad I/E criteria. However, because our Real-Time Feasibility Dashboard integrates EMR and geometric data, we can give you up to date insights on your target patients. Learn more here: https://bit.ly/3Hl16k6

Our team is loving . It's great to be together talking about clinical trial matching in person.

📌 Meet the Deep Lens team at the 2022 ASCO Annual Meeting on June 3 - 7, 2022, the most significant oncology research gathering of the year.

Learn more about the Annual Meeting, attendance registration, and the innovative technology which Deep Lens use to help support the diversity in the clinical research here https://bit.ly/3wFkkx9

Good Morning SCRS Diversity! Stay tuned with us to know more about oncology clinical research solutions and many inspiring successful stories!

We will be here tomorrow at Hilton Austin, the 2022 Global Oncology Site Solutions Summit venue. Meet us there and contact us for a meetup! https://bit.ly/3wa2bYg

# AI

identifies and matches patients to precision trials in the narrow window of opportunity through lab-agnostic genomic data ingestion.
Download our brochure to learn more about VIPER technology presented by . 👉https://bit.ly/3NemtoS

1 Week to go... Have you registered?
Let us know if you will be at the SCRS Diversity Site Solutions Summit on May 20, 2022, and the 2022 Global Oncology Site Solutions Summit in Austin, Texas, on May 21 and 22, 2022.

Contact us for a meetup; let’s work together for better clinical research solutions!

Know more about the summit and the technology which Deep Lens uses to help support the diversity in the clinical research here https://bit.ly/39lcBLH

# AI

Are Cell and Gene Therapy Programs Primed for Community Oncology? https://bit.ly/39emV86

Are Cell and Gene Therapy Programs Primed for Community Oncology? Deep Lens' Director of Provider Network Amy Zuchelkowski shares her perspective on bringing cell and gene therapies to community oncology practices.

VIPER optimizes the enrollment process to help you capture more patients, but how does it work? Download our infographic here to learn more: https://bit.ly/3KurqZi

"It is estimated that cancer therapies take 30%-40% longer than other indications to gain approval"

Discover what T.J. Bowen has to say in his interview with InterventOnc360 here: https://bit.ly/3x3UWBW

Discover How VIPER Solves the 5 Biggest Patient Recruitment Problems for Providers.

https://bit.ly/3DJjaCI

Deep Lens is looking for a Regulatory Specialist to join the team and manage regulatory documents.

If you qualify, please apply for the role here: https://bit.ly/3Jcb3zU

Our Real Time Feasibility Dashboard surfaces the patients that are eligible for trials now and those who may become eligible as their treatment progresses. Learn more here: https://bit.ly/3hpvA8A

Most clinical trial research sites under enroll patients. Our Real Time Feasibility Dashboard enables you to discover the best sites to activate for your trials: https://bit.ly/3M9wWCo

By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines by finding the best-suited patients for clinical trials. Learn more about how we help BioPharma and CROs here: https://bit.ly/3poPdBU

By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines by finding the best-suited patients for clinical trials. Learn more about how we help BioPharma and CROs here: https://bit.ly/3pmzjIx

By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines by finding the best-suited patients for clinical trials.

Learn more about how we help BioPharma and CROs here: https://bit.ly/36AEAFB

Our team is growing!
If you’re looking for a new challenge in an innovative, high-energy environment, check out our current openings to see if there might be a match.

https://bit.ly/33t2dyH

Meet Mark Vance, VP of Technology at Deep Lens. Mark is a proven innovator with experience moving technology-driven products from idea to market in academic, corporate and start-up environments. Learn more about our accomplished leader here: https://bit.ly/3GXjk9A

Our team is growing!
If you’re looking for a new challenge in an innovative, high-energy environment, check out our current openings to see if there might be a match.

Ready to bring your A-game?

Current Positions:

CRC Consultant
Genomic Product Owner
Clinical Project Manager
Data Engineer
Full-Stack Developer
Provider Sales Director
CRO Sales Director
CRO Account Manager


https://bit.ly/354UJCG

Our Real-Time Feasibility Dashboard provides insight into patient eligibility, enabling you to make better decisions on site selection and study activation.
Learn more here: https://bit.ly/3GYnRbT

Meet Charlie Vonderahe - Charlie began his healthcare career with McKesson, serving as an advisor to independent pharmacists and helping them adapt to changing standards of care in a tumultuous reimbursement landscape.

Charlie is excited to have a court-side seat to at least a small part of what he thinks will go down in history (history was his undergraduate degree – no math whatsoever) as the best thing people did with the first waves of artificial intelligence: extend and improve each other’s lives.

https://bit.ly/3Jwi3Id

Meet Tyrone - Tyrone has been a commercial sales executive in the oncology diagnostics and molecular profiling sector for over 15 years. Prior to joining Deep Lens in 2021, Tyrone was a Regional Business Director at Caris Life Sciences where he led a team of sales representatives.

https://bit.ly/3LEY9N2

Applying AI to Improve Efficiencies in Clinical Trials - Featuring Dave Billiter, Deep Lens Founder and CEO. - THURSDAY, FEBRUARY 10

Artificial Intelligence has the potential to dramatically improve the speed and accuracy of clinical trials. Medical and operational experts can incorporate AI algorithms into use cases that include automation of image analysis, predictive analytics about trends in the metadata, and tailored patient engagement for improved compliance.

Join Dave and the panel as they discuss opportunities for AI to help sponsor and site stakeholders focus more on patient outcomes and perform their jobs more effectively.

https://bit.ly/3JcC7zp

CHI's Artificial Intelligence in Clinical Research Conference - Part of SCOPE 2022 AI and Advanced Analytics to Support Clinical Trial Transformation February 9-10, 2022 - Orlando, FL + Virtual

Are you heading to SCOPE: Summit for Clinical Ops Executives? Dave Billiter, Deep Lens Co-Founder and CEO will be attending and looking forward to meeting up.

https://bit.ly/3owb0at

13th Annual SCOPE: Summit for Clinical Ops Executives (In-Person & Online) | LinkedIn Now more than ever, the important work of this clinical research community requires collaboration and innovation. Now in its 13th year of fostering these goals, SCOPE Summit 2022 will take place February 7-10, 2022 in Orlando, FL at a new location, the Rosen Shingle Creek. Over four stimulating days...

Stale historical data is often only the best guess on broad I/E criteria. However, because our Real-Time Feasibility Dashboard integrates EMR and geometric data, we can give you up to date insights on your target patients: https://bit.ly/3KAFxgO

By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines. Learn more about how we help BioPharma and CROs here: https://bit.ly/3KFXLgL

Does your clinical research department perform site audits or take other measures to ensure the quality of data submitted with a new drug application (NDA)?

https://bit.ly/341RyLe

On the Importance of Self-Audits in Clinical Research Deep Lens' Director of Provider Network Amy Zuchelkowski shares her perspective on preparing for FDA audits through diligence in reporting and record keeping.

Stale historical data is often only the best guess on broad I/E criteria. However, because our Real-Time Feasibility Dashboard integrates EMR and geometric data, we can give you up to date insights on your target patients: https://bit.ly/3rJcsXP

Meet Ryan, our passionate and experienced Senior Machine Learning Engineer. At Deep Lens, he takes pride in developing AI models that extract as much relevant information needed to match as many eligible patients as possible to clinical trials. Discover the rest of our team here: https://bit.ly/3rqgioA

Trial Matching & Notification

VIPER searches the customized matching engine to find the best available clinical trials for a patients’ specific diagnosis—at the time of diagnosis.

Through workflow integration, VIPER sends real-time notifications of a patient's eligibility for available clinical trials to the entire care team in the narrow enrollment window. https://bit.ly/3Fxbp2d

Deep Lens | Healthcare Providers Deep Lens’ AI driven cloud platform gives care teams, trial coordinators and oncologists visibility into all available trials across all cancer types.

|| Our Story ||
The initial idea for Deep Lens came together when the founders, Dave, Simon and TJ, realized that Dave's digital pathology inventions from his days as head of innovation at Nationwide Children's Hospital could form the basis for a completely rethought approach to clinical trial recruitment.


https://bit.ly/3Ig2DqU

Cumbersome feasibility questionnaires are time-consuming to build and analyze. But with our easy-to-use Real-Time Feasibility Dashboard, you can get all the info you need at a glance. Learn more here: https://bit.ly/3FB8WUb

Are Cell and Gene Therapy Programs Primed for Community Oncology? https://bit.ly/3FGCpfw

Are Cell and Gene Therapy Programs Primed for Community Oncology? Deep Lens' Director of Provider Network Amy Zuchelkowski shares her perspective on bringing cell and gene therapies to community oncology practices.

Case Study - Discover how Deep Lens activated a new site and configured VIPER to make the process seamless.

Read our case study to understand how Deep Lens and VIPER technology overcame several underlying issues to result in successful recruitment within weeks.

https://bit.ly/3nySGNi